GC establishes generative AI platform Hey GC

This platform features internal data analysis, standard platform structure, chatbot functionality

GC establishes generative AI platform Hey GC
Young-Ae Lee 1
2024-11-12 16:45:00 0ae@hankyung.com
Bio & Pharma

South Korea's Green Cross Holdings Corp. (GC) said on Tuesday it established its generative AI standard platform Hey.GC.

Hey.GC is designed to improve work efficiency through internal data analysis, external resource searches, and a standardized platform structure.

Along with the platform, a chatbot service integrating generative AI for work applications has also been launched. This service includes a My AI feature, allowing employees to easily create their customized chatbots for workplace use.

GC expects this platform to contribute to future growth by continuously enhancing the generative AI platform, updating features, and expanding services.

GC implemented Brain X GPT, a chatbot solution developed by the domestic AI specialist In4U&Company, to boost security and stability.

This system ensures that internal information is protected from external intrusions.

Write to Young-Ae Lee at 0ae@hankyung.com

GC Biopharma sells HK subsidiary to CR Pharm Group for $254 mn

GC Biopharma sells HK subsidiary to CR Pharm Group for $254 mn

South Korea’s GC Biopharma Corp. announced on Wednesday that it signed a share purchase agreement (SPA) to sell all its shares in its Hong Kong subsidiary to a subsidiary of China Resources Pharmaceutical Group.The total sale amount is 350 billion won ($254 million). Last year, China Res

GC Biopharma exports Alyglo to US

GC Biopharma exports Alyglo to US

South Korea’s major pharmaceutical company GC Biopharma Corp. announced on Monday that it shipped the initial volume of Alygro, its immunoglobulin blood product to enter the US market.  Alyglo, which received approval from the US Food and Drug Administration (FDA) in December l

(* comment hide *}